Trial intelligence / Profile preview

Phase 3 favipiravir versus placebo in adults with uncomplicated influenza

2013-002149-13Phase 3Completed

Sponsor
MDVI, LLC
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in influenza comparing Favipiravir with Placebo (2 arms). Primary endpoint: Time to alleviation of all primary influenza symptoms and fever resolution. Started Jul 2013; status: completed.

02

Drugs

favipiravir
03

Conditions

influenza

Beyond the preview

Go deeper on 2013-002149-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002149-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call